Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control.
World's first Glycated albumin test for Point-of-care
Glycated Albumin is a kind of glycosylated protein and is the result of a covalent linkage between glucose and albumin. Similar to HbA1c, Glycated Albumin can be used to monitor long-term control of glucose in diabetics. It has a shorter half-life than HbA1c and is thought to be more sensitive to short-term fluctuations in glucose concentrations. Some HbA1c methods are affected by hemoglobin variants. Glycated Albumin is not subject to this interference.
Glycated Albumin reflects average blood glucose concentration over the previous 2-4 weeks; used in the management of insulin therapy for diabetes mellitus. Glycated Albumin rapidly confirms treatment efficacy due to a shorter half-life than HbA1c.
How is Microalbumin treated in diabetes?
Diabetic nephropathy is a serious kidney-related complication of type 1 diabetes and types 2 diabetes. It is also called diabetic kidney disease. About 25% of people with diabetes eventually develop kidney disease. Diabetic nephropathy affects the kidneys' ability to do their usual work of removing waste products and extra fluid from the body. Healthy kidneys filter waste from the blood and hang on to the healthy components, including proteins such as albumin. Kidney damage can cause proteins to leak through the kidneys and exit the body in your urine. Albumin is one of the first proteins to leak when kidneys become damaged.
A urine microalbumin test is a test^-^ to detect very small levels of blood protein (albumin) in the urine, so the test is used to detect early signs of kidney damage in people who are at risk of developing kidney disease. The high levels of microalbumin in urine mean kidney damage or chronic kidney disease, the presence of microalbumin in urine can therefore be an important marker for cardiovascular and renal risk in diabetes mellitus.
Total Glycemic controls as HbA1c, Glycated Albumin, and Microalbumin could have a powerful impact to improve patient outcome and control the costs of diabetes. The measurement of the markers directly linked to several of the most serious complications of diabetes. Those markers are a better reflection of the efficacy of treatment than other tests and also It has recently been shown to be an effective marker to screen for diabetes at an early stage. Moreover, If GA testing can be brought into widespread general use, it has the potential to bring about real and significant improvements in diabetes care.
Glycated Albumin reflects average blood glucose concentration over the previous 2-4 weeks; used in the management of insulin therapy for diabetes mellitus. Glycated Albumin rapidly confirms treatment efficacy due to shorter half-life than HbA1c.
Boronate affinity principle
4.0 ~ 40.0 %
< 10 %
2 ~ 10 °C
Epithod® GA Test Kit
(*) Special cold packing
Yellow tip, 1,000 pcs/pack
Thermal printer paper
(*) Special packing charge will be imposed under MOQ.